Nabriva Therapeutics plc logo
Nabriva Therapeutics plc NBRV
$ 1.42 0.0%

Quarterly report 2023-Q1
added 05-22-2023

report update icon

Nabriva Therapeutics plc EV/EBITDA Ratio 2011-2024 | NBRV

Annual EV/EBITDA Ratio Nabriva Therapeutics plc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.417 -5.26 -12.5 -7.83 -25.8 -2.62 -6.14 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.417 -25.8 -8.54